Immunobioinformatics analysis and phylogenetic tree construction of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Indonesia: spike glycoprotein gene
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has spread worldwide and as a result, the World Health Organization (WHO) declared it a pandemic. At present, there are no approved vaccines against SARS-CoV-2. Therefore, the aim of this study was to predict epitope-based vaccines using bioinformatics approaches and phylogenetic tree construction of SARS-CoV-2 against the backdrop of the COVID-19 pandemic. In this study, we employed 27 isolates of SARS-CoV-2 spike glycoprotein genes retrieved from GenBank® (National Center for Biotechnology Information, USA) and the GISAID EpiCoV™ Database (Germany). We analyzed the candidate epitopes using the Immune Epitope Database and Analysis Resource. Furthermore, we performed a protective antigen prediction with VaxiJen 2.0. Data for B-cell epitope prediction, protective antigen prediction, and the underlying phylogenetic tree of SARS-CoV-2 were obtained in this research. Therefore, these data could be used to design an epitope-based vaccine against SARS-CoV-2. However, the advanced study is recommended for confirmation (in vitro and in vivo)..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Jurnal Teknologi Laboratorium - 9(2020), 1, Seite 13-20 |
Sprache: |
Indonesisch |
---|
Beteiligte Personen: |
Arif Nur Muhammad Ansori [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Coronavirus |
---|
doi: |
10.29238/teknolabjournal.v9i1.221 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ006650279 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ006650279 | ||
003 | DE-627 | ||
005 | 20230309205236.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230225s2020 xx |||||o 00| ||ind c | ||
024 | 7 | |a 10.29238/teknolabjournal.v9i1.221 |2 doi | |
035 | |a (DE-627)DOAJ006650279 | ||
035 | |a (DE-599)DOAJ8af95852bbce499fa46d13044e8f3f5c | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a ind | ||
050 | 0 | |a R5-920 | |
100 | 0 | |a Arif Nur Muhammad Ansori |e verfasserin |4 aut | |
245 | 1 | 0 | |a Immunobioinformatics analysis and phylogenetic tree construction of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Indonesia: spike glycoprotein gene |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has spread worldwide and as a result, the World Health Organization (WHO) declared it a pandemic. At present, there are no approved vaccines against SARS-CoV-2. Therefore, the aim of this study was to predict epitope-based vaccines using bioinformatics approaches and phylogenetic tree construction of SARS-CoV-2 against the backdrop of the COVID-19 pandemic. In this study, we employed 27 isolates of SARS-CoV-2 spike glycoprotein genes retrieved from GenBank® (National Center for Biotechnology Information, USA) and the GISAID EpiCoV™ Database (Germany). We analyzed the candidate epitopes using the Immune Epitope Database and Analysis Resource. Furthermore, we performed a protective antigen prediction with VaxiJen 2.0. Data for B-cell epitope prediction, protective antigen prediction, and the underlying phylogenetic tree of SARS-CoV-2 were obtained in this research. Therefore, these data could be used to design an epitope-based vaccine against SARS-CoV-2. However, the advanced study is recommended for confirmation (in vitro and in vivo). | ||
650 | 4 | |a coronavirus | |
650 | 4 | |a epitope-based vaccine | |
650 | 4 | |a immunobioinformatics | |
650 | 4 | |a phylogenetic tree | |
650 | 4 | |a sars-cov-2 | |
653 | 0 | |a Medicine (General) | |
700 | 0 | |a Viol Dhea Kharisma |e verfasserin |4 aut | |
700 | 0 | |a Yulanda Antonius |e verfasserin |4 aut | |
700 | 0 | |a Martia Rani Tacharina |e verfasserin |4 aut | |
700 | 0 | |a Fedik Abdul Rantam |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Jurnal Teknologi Laboratorium |d Poltekkes Kemenkes Yogyakarta, 2017 |g 9(2020), 1, Seite 13-20 |w (DE-627)DOAJ000130052 |x 25800191 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2020 |g number:1 |g pages:13-20 |
856 | 4 | 0 | |u https://doi.org/10.29238/teknolabjournal.v9i1.221 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/8af95852bbce499fa46d13044e8f3f5c |z kostenfrei |
856 | 4 | 0 | |u https://teknolabjournal.com/index.php/Jtl/article/view/221 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2338-5634 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2580-0191 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 9 |j 2020 |e 1 |h 13-20 |